"Retex" β-hydroxybutyric acid reagent - Taiwan Registration 6cde33d468280f42243bbb1a570e0036
Access comprehensive regulatory information for "Retex" β-hydroxybutyric acid reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 6cde33d468280f42243bbb1a570e0036 and manufactured by RANDOX LABORATORIES LTD. The authorized representative in Taiwan is KUO'S YUAN IN ENTERPRISE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
For in vitro quantification of β-hydroxybutyric acid in serum and plasma. This product is suitable for use with RX monza analytical instruments.
A Clinical chemistry and clinical toxicology
A.1435 Trial (non-quantitative) strains;; A.1150 Calibrated Products
QMS/QSD;; 輸入
Dates and Status
Jul 29, 2021
Jul 29, 2026